References
Dye C, Sheele S, Dolin P, et al. Global burden of tuberculosis. JAMA 1999; 282: 677–86
American College of Obstetrics and Gynecology. Pulmonary disease in pregnancy. Washington, DC: American College of Obstetrics and Gynecology, 1996 Jun. Technical Bulletin No. 224
Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New Engl J Med 1993; 328: 527–32
Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Safety 2001; 24(7): 553–65
Hageman J, Shulman S, Schreiber M, et al. Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics 1980; 66: 980
Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536–48
Centers for Disease Control. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993; 42(7): 1–8
British National Formulary. No. 42. London. The Pharmaceutical Press, 2001 Sept: 280-5
Davidson PT. Treating tuberculosis: what drugs, for how long? Ann Intern Med 1990; 112: 393–4
Wachstein M. Evidence for a relative B6 deficiency in pregnancy and some disease states. Vitam Horm 1964; 22: 705–19
Volmink J, Malchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000; 355: 1345–50
Aquinas M, Allan WGL, Horsfall PAL, et al. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. BMJ 1972; 1: 765–71
Riska N. Hepatitis cases in isoniazid groups and in a control group. Bull Int Union Tuberc 1976; 51: 203–6
Stele MA, Burk RF, DesPrex RM. Toxic hepatitis with isoniazid and rifampicin: a meta-analysis. Chest 1991; 99: 465–71
Iseman MD, Miller B. If a tree falls in the middle of the forest. Am Rev Respir Dise 1989; 140: 575–6
Snider DE Jr, Layde PM, Johnson MW, et al. Treatment of tuberculosis in pregnancy. Am Rev Respir Dis 1980; 122: 65–79
Einarson A, Phillips E, Mawji F, et al. A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 1998; 15: 523–5
Varpela E. On the effect exerted by first-line tuberculosis medicines on the foetus. Acta Tuberc Pneumol Scand 1964; 35: 53–69
Potworoska M, Sianozecka E, Szufladowicz M. Ethionamide treatment and pregnancy. Pol Med J 1966; 5: 1152–8
Rights and permissions
About this article
Cite this article
Effective treatment of primary presentation vital for management of tuberculosis in pregnancy. Drugs Ther. Perspect 18, 10–12 (2002). https://doi.org/10.2165/00042310-200218030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200218030-00004